NCT02302690View on ClinicalTrials.gov

Immunity Against AAV in Crigler Najjar Patient

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Crigler Najjar Syndrome
Interventions
BIOLOGICAL

Blood sample for immunology

Trial Locations (1)

92141

Hopital Antoine Béclère, Clamart

Sponsors

Lead Sponsor

Genethon
All Listed Sponsors
lead

Genethon

OTHER

NCT02302690 - Immunity Against AAV in Crigler Najjar Patient | Biotech Hunter | Biotech Hunter